En
Home
Guidelines for Hemophilia
Principles Of Care
Comprehensive care of hemophilia
Laboratory diagnosis and monitoring
Genetic assessment
Hemostatic agents and Prophylaxis
Treatment of specific hemorrhages
Inhibitors to clotting factor
Specific management issues
Musculoskeletal complications
Outcome assessment
AAV Gene Therapy
About the WFH Guidelines
Governance
Guideline Resources
Guideline Development Process
Guidelines Past Versions
Public Review & External Input
Panelists
Panelists
Guidelines for VWD
Contact Us
News & Updates
Menu
Home
Guidelines for Hemophilia
Principles Of Care
Comprehensive care of hemophilia
Laboratory diagnosis and monitoring
Genetic assessment
Hemostatic agents and Prophylaxis
Treatment of specific hemorrhages
Inhibitors to clotting factor
Specific management issues
Musculoskeletal complications
Outcome assessment
AAV Gene Therapy
About the WFH Guidelines
Governance
Guideline Resources
Guideline Development Process
Guidelines Past Versions
Public Review & External Input
Panelists
Panelists
Guidelines for VWD
Contact Us
News & Updates
Home
>
Guidelines for the Management of Hemophilia
>
Guidelines Past Versions
Past Versions
Chapter 1
2020 Version
2012 Version
2007 Version
